Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00051857 · ClinicalTrials.gov registry record

MRI Study of Musculoskeletal Function

A clinical trial of Patellofemoral Pain Syndrome and Abnormalities, sponsored by National Institutes of Health Clinical Center (CC).

Recruiting
Registry status
750
Enrollment target
1
Study location

NCT00051857: Recruiting study of Patellofemoral Pain Syndrome and Abnormalities, sponsored by National Institutes of Health Clinical Center (CC).

NCT00051857 is a study of Patellofemoral Pain Syndrome and Abnormalities that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 750 participants, above the 71-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (956% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00051857, a study of Patellofemoral Pain Syndrome and Abnormalities, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).

RECRUITING
Registry status
750 participants
Enrollment target
1
Study location

Study Summary

This study will use magnetic resonance imaging (MRI) and ultrasound images to study how muscles, tendons, and bones work together to cause motion. The procedure is one of several tools being developed to characterize normal and impaired musculoskeletal function, with the goal of developing improved methods of diagnosis and treatment of movement disorders. Healthy normal volunteers must be age 5 to unlimited, with or without joint impairment, may be eligible for this study. Volunteers with joint impairment may not have serious injury to the joint being studied, previous surgery on the joint being studied, or extreme pain at the joint being studied. MRI uses a strong magnet and radio waves to create images of the inside of the body. The subject lies on a long narrow couch inside a metal cylinder (the scanner) for up to 3 hours while the scanner gathers data. Earplugs are worn to muffle loud noises caused by electrical switching of radiofrequency circuits used in the scanning process. A special pad or tube may be placed over or around the region being scanned to improve the quality of the data. The subject will be asked to repeatedly move a specific joint, such as the knee, for brief periods, usually less than 5 minutes. The subject can communicate via intercom with the person performing the study at all times during the procedure, and may request to stop the study at any time.

Primary Outcome

MRI techniques to non-invasively measure the 3D in vivo musculoskeletal kinematics, bone shapes, and muscle-tendon lengths in the joints of normal volunteers and healthy volunteers with specific joint impairments.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2003-03-05

What NCT00051857 shows while recruiting

NCT00051857 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 71-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (956% higher).

The record links to 3 conditions, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00051857 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00051857 about?

NCT00051857 is a clinical study titled "MRI Study of Musculoskeletal Function". This study will use magnetic resonance imaging (MRI) and ultrasound images to study how muscles, tendons, and bones work together to cause motion. The procedure is one of several tools being developed to characterize normal and impaired musculoskeletal function, with the goal of developing improved ...

What is the current status of trial NCT00051857?

This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2003-03-05.

What conditions does trial NCT00051857 study?

This clinical trial studies the following conditions: Patellofemoral Pain Syndrome, Abnormalities, Imaging.

Who is sponsoring clinical trial NCT00051857?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00051857 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00051857's enrollment target sits among peer trials

750 1st of 10 higher than 10 of 10 other Patellofemoral Pain Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Patellofemoral Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00051857, the US trial registry maintained by the National Library of Medicine. NCT00051857 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.